Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Human Vaccines & Immunotherapeutics|July 17, 2013
Preclinical evaluation of Vaxfectin-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccinesLarry R Smith, Walter Wodal, Brian A Crowe, et al.Plos One|February 2, 2011
Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunityAnnett Hessel, Michael Schwendinger, Georg W Holzer, et al.Plos One|February 27, 2015
Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigsWalter Wodal, Michael G Schwendinger, Helga Savidis-Dacho, et al.Plos One|September 3, 2010
A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizationsAnnett Hessel, Michael Schwendinger, Daniela Fritz, et al.Vaccine|July 7, 2007
Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responsesOtfried Kistner, M Keith Howard, Martin Spruth, et al.Clinical and Vaccine Immunology : CVI|April 18, 2014
Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patientsMaikel V W van der Velden, Alexander Geisberger, Thomas Dvorak, et al.Journal of Virology|March 13, 2009
Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protectionJosef Mayrhofer, Sogue Coulibaly, Annett Hessel, et al.Plos One|February 27, 2010
A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse modelsOtfried Kistner, Brian A Crowe, Walter Wodal, et al.Clinical and Vaccine Immunology : CVI|September 5, 2014
A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu latoNina Wressnigg, P Noel Barrett, Eva-Maria Pöllabauer, et al.The Lancet. Infectious Diseases|May 14, 2013
Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trialNina Wressnigg, Eva-Maria Pöllabauer, Gerald Aichinger, et al.Pageof 2